| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 93 |
| 1 | ADALIMUMAB | 60 |
| 2 | METHOTREXATE SODIUM | 45 |
| 3 | METHOTREXATE | 38 |
| 4 | TOFACITINIB | 29 |
| 5 | PREDNISONE | 28 |
| 6 | LEFLUNOMIDE | 27 |
| 7 | UPADACITINIB | 27 |
| 8 | ABATACEPT | 26 |
| 9 | ALENDRONATE SODIUM | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AAMLODIPINE AND OLMESARTAN MEDOXOMIL | 1 | 0.0049 |
| 1 | L DOPA | 1 | 0.0037 |
| 2 | ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX (HUMAN) | 2 | 0.0018 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 4 | 0.0014 |
| 4 | CLINDAMYCIN PHOSPHATE | 6 | 0.0011 |
| 5 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 1 | 0.0009 |
| 6 | GOLIMUMAB | 10 | 0.0008 |
| 7 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 8 | CHLORZOXAZONE | 1 | 0.0008 |
| 9 | PSYLLIUM HUSK | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 117 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 2 | Corticosteroid [EPC] | 43 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 38 |
| 4 | Janus Kinase Inhibitor [EPC] | 34 |
| 5 | Antirheumatic Agent [EPC] | 27 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 26 |
| 7 | Interleukin-23 Antagonist [EPC] | 22 |
| 8 | Vitamin C [EPC] | 22 |
| 9 | Vitamin D [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 2 | 0.0006 |
| 1 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 2 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 3 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 4 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Antirheumatic Agent [EPC] | 27 | 0.0003 |
| 6 | Cephalosporin Antibacterial [EPC] | 2 | 0.0002 |
| 7 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 9 | Janus Kinase Inhibitor [EPC] | 34 | 0.0002 |